Source: Pharma Japan
6 June 2014
Trans-Pacific Partnership (TPP) free-trade talks involving a dozen economies are making little headway in the area of intellectual property, the Japanese government told trade groups on June 2.
The Cabinet Secretariat’s TPP task force held a closed-door briefing on the same day for industry associations regarding a ministerial meeting in Singapore on May 19-20. “Although the discussions are now in the final stage, the final stage is most difficult,” Kazuhisa Shibuya, councilor of the Cabinet Secretariat, said in his opening speech.
The Cabinet Secretariat told reporters following the briefing that “negotiations have faced tough sledding” in the field of IP, including data protection periods for pharmaceuticals.
The countries apparently remain at odds, with Japan and the US calling for a long data exclusivity period for drugs, while emerging economies are opposing this as they want early access to low-cost generics.